1. McMahon M, Williams H, Debie E, Fu M, Bujalski R, et al. Utilization of risk-based Predictive Stability within Regulatory submissions: Industry’s experience. AAPS Open. 2020;6:1.
2. Qiu F, Scrivens G. Accelerate Predictive Stability (APS): fundamentals and Pharmaceutical Industry practices. Cambridge, MA: Academic; 2018.
3. Williams H, Stephens D, McMahon M, Debie E, Qiu F, Hyzer CH, Sechler L, Orr R, Webb D, Wu Y, Hahan D. Risk-based Predictive Stability – An Industry Perspective. Pharm Tech. 2017;41(3):52–7.
4. Bajaj S, Singla D, Sakhuja N. Stability Testing of Pharmaceutical products. J App Pharm Sci. 2012;02(03):129–38.
5. McMahon M, Abbott A, Babayan Y, Carhart J, Chen C, Debie E, Fu M, et al. Considerations for updates to ICH Q1 and Q5C Stability guidelines: Embracing Current Technology and Risk Assessment Strategies. AAPS J. 2021;23:107.